Related references
Note: Only part of the references are listed.SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids
Jitske Jansen et al.
CELL STEM CELL (2022)
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons
Ching Ying Huang et al.
CELL REPORTS (2022)
Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with PKD1 Mutation
Aung Khine Linn et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
Shigeru Miyagawa et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Organs-on-chips: into the next decade
Lucie A. Low et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine
Ziwei Pan et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2021)
iPSC technology-based regenerative medicine for kidney diseases
Kenji Osafune
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2021)
Potential of Drug Efficacy Evaluation in Lung and Kidney Cancer Models Using Organ-on-a-Chip Technology
Seong-Hye Hwang et al.
MICROMACHINES (2021)
Generation of induced pluripotent stem cells from a Bardet-Biedl syndrome patient carrying a homologous BBS2 c.534+1G > T mutation
Chien-Yu Ting et al.
STEM CELL RESEARCH (2021)
Efficient derivation of human trophoblast stem cells from primed pluripotent stem cells
Yanxing Wei et al.
SCIENCE ADVANCES (2021)
Human iPSC modeling of heart disease for drug development
Anna P. Hnatiuk et al.
CELL CHEMICAL BIOLOGY (2021)
Tissue Chips in Space-Challenges and Opportunities
Catherine K. Yeung et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery
Arun Sharma et al.
CELL STEM CELL (2020)
Derivation of trophoblast stem cells from naive human pluripotent stem cells
Chen Dong et al.
ELIFE (2020)
Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9
Chun-Lin Liu et al.
STEM CELL RESEARCH (2020)
A Modular Differentiation System Maps Multiple Human Kidney Lineages from Pluripotent Stem Cells
Hiraku Tsujimoto et al.
CELL REPORTS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Infection of bat and human intestinal organoids by SARS-CoV-2
Zhou Jie et al.
NATURE MEDICINE (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
Liuliu Yang et al.
CELL STEM CELL (2020)
An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs
Svenja Koslowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PKD1-Dependent Renal Cystogenesis in Human Induced Pluripotent Stem Cell-Derived Ureteric Bud/Collecting Duct Organoids
Shohei Kuraoka et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs
Tatsuya Shimizu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Effects of COVID-19 on the Nervous System
Costantino Iadecola et al.
CELL (2020)
Pluripotent Stem Cell-Based Cell Therapy- Promise and Challenges
Shinya Yamanaka
CELL STEM CELL (2020)
SARS-CoV-2 targets neurons of 3D human brain organoids
Anand Ramani et al.
EMBO JOURNAL (2020)
Expansion of Human iPSC-Derived Ureteric Bud Organoids with Repeated Branching Potential
Shin-Ichi Mae et al.
CELL REPORTS (2020)
SARS-CoV-2 renal tropism associates with acute kidney injury
Fabian Braun et al.
LANCET (2020)
iPS cell-based therapy for Parkinson's disease: A Kyoto trial
Jun Takahashi
Regenerative Therapy (2020)
Human Pluripotent Stem Cell-Derived Kidney Organoids with Improved Collecting Duct Maturation and Injury Modeling
Kohei Uchimura et al.
CELL REPORTS (2020)
Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
Florian Tran et al.
FRONTIERS IN IMMUNOLOGY (2020)
Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines-lessons from establishing the Taiwan human disease iPSC Consortium Bank
Ching-Ying Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection
Arun Sharma et al.
CELL REPORTS MEDICINE (2020)
Scaffolding kidney organoids on silk
Ashwani Kumar Gupta et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2019)
Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells
Elena Garreta et al.
NATURE MATERIALS (2019)
Flow-enhanced vascularization and maturation of kidney organoids in vitro
Kimberly A. Homan et al.
NATURE METHODS (2019)
Kidney organoids: accurate models or fortunate accidents
Melissa H. Little et al.
GENES & DEVELOPMENT (2019)
INDUCED PLURIPOTENT STEM CELLS AND THEIR USE IN HUMAN MODELS OF DISEASE AND DEVELOPMENT
Peter Karagiannis et al.
PHYSIOLOGICAL REVIEWS (2019)
Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes
Jia-Jung Lee et al.
EBIOMEDICINE (2019)
iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases
Chuang-Yu Lin et al.
JCI INSIGHT (2019)
Overview: an iPS cell stock at CiRA
Masafumi Umekage et al.
INFLAMMATION AND REGENERATION (2019)
Human iPSC banking: barriers and opportunities
Ching-Ying Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms
Thomas A. Forbes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Generation of branching ureteric bud tissues from human pluripotent stem cells
Shin-Ichi Mae et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Kacey Ronaldson-Bouchard et al.
CELL STEM CELL (2018)
High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping
Stefan M. Czerniecki et al.
CELL STEM CELL (2018)
Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond
Chun Liu et al.
DEVELOPMENT (2018)
Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates
Yen-Wen Liu et al.
NATURE BIOTECHNOLOGY (2018)
Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells
Ryuji Morizane et al.
NATURE PROTOCOLS (2017)
Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2
Ming-Ching Ho et al.
STEM CELL RESEARCH (2017)
Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation
Jia-Jung Lee et al.
STEM CELL RESEARCH (2017)
Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience
Paul A. De Sousa et al.
STEM CELL RESEARCH (2017)
Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1
Ching-Ying Huang et al.
STEM CELL RESEARCH (2017)
Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells
Jung-Hyun Kim et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Higher-Order Kidney Organogenesis from Pluripotent Stem Cells
Atsuhiro Taguchi et al.
CELL STEM CELL (2017)
Autosomal dominant polycystic kidney disease: the changing face of clinical management
Albert C. M. Ong et al.
LANCET (2015)
Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis
Minoru Takasato et al.
NATURE (2015)
Nephron organoids derived from human pluripotent stem cells model kidney development and injury
Ryuji Morizane et al.
NATURE BIOTECHNOLOGY (2015)
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
Benjamin S. Freedman et al.
NATURE COMMUNICATIONS (2015)
A comparison of non-integrating reprogramming methods
Thorsten M. Schlaeger et al.
NATURE BIOTECHNOLOGY (2015)
Redefining the In Vivo Origin of Metanephric Nephron Progenitors Enables Generation of Complex Kidney Structures from Pluripotent Stem Cells
Atsuhiro Taguchi et al.
CELL STEM CELL (2014)
Human embryonic-stem-cell-derived cardiomyocytesregenerate non-humanprimate hearts
James J. H. Chong et al.
NATURE (2014)
Efficient and Rapid Induction of Human iPSCs/ESCs into Nephrogenic Intermediate Mesoderm Using Small Molecule-Based Differentiation Methods
Toshikazu Araoka et al.
PLOS ONE (2014)
Reduced Ciliary Polycystin-2 in Induced Pluripotent Stem Cells from Polycystic Kidney Disease Patients with PKD1 Mutations
Benjamin S. Freedman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells
Shin-Ichi Mae et al.
NATURE COMMUNICATIONS (2013)
Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
Antje D. Ebert et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Development of Defective and Persistent Sendai Virus Vector A UNIQUE GENE DELIVERY/EXPRESSION SYSTEM IDEAL FOR CELL REPROGRAMMING
Ken Nishimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1
Momoko Maekawa et al.
NATURE (2011)
Induced pluripotent stem cells and personalized medicine: current progress and future perspectives
Yong Soon Chun et al.
ANATOMY & CELL BIOLOGY (2011)
The Nuclear Receptor Nr5a2 Can Replace Oct4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells
Jian-Chien Dominic Heng et al.
CELL STEM CELL (2010)
The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on
Jeremy Micah Crook et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2010)
The cell biology of polycystic kidney disease
Hannah C. Chapin et al.
JOURNAL OF CELL BIOLOGY (2010)
Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts
Noriko Tsubooka et al.
GENES TO CELLS (2009)
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome
Noemi Fusaki et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons
John T. Dimos et al.
SCIENCE (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Autosomal dominant polycystic kidney disease
Vicente E. Torres et al.
LANCET (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Share Paper
